🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Looking forward to this afternoon’s session. If you are at ASHG and interested in genetics in drug discovery come along and ask us about what we are doing at Novo Nordisk, GSK, AZ, Pfizer and Roche in room 143 at 3:30pm today

Yes! Do check out opportunities Jonathan Mill and I are also recruiting a bioinformatics postdoc working on transcriptional and epigenetic variation in the brain! medicine.exeter.ac.uk/clinical-biome…

We have a postdoc position available for 3-4 years, if anyone is interested in coming to rainy Oxford! The lab is diverse, friendly and very supportive. I don't travel much, still tinker with microscopes, and have an open door policy. DM me if interested! jobs.ac.uk/job/DGH876/pos…

I am delighted to share that @nature and Sony have just announced a launch of a new award - Women in Technology! The focus is on women in early & mid-career. Applications close May 31st. Apply & help spread the word! #womenintech #womeninSTEM womenintechnology.sony.com

Health Data Research UK (HDR UK) Seminar Joanna Howson from Novo Nordisk on how human genetics can identify potential targets in cardiometabolic disease & future plans to help develop patient therapies 🗓️28 March 10:00 at VPD-Heart & Lung Institute in Cambridge or online. Info tinyurl.com/2xhptu22

Congratulations Yuyang, fantastic work from you and the wider collaboration!

Well done Nicky!! And an informative thread. Look forward to hearing others thoughts on it 🤗

We are hosting the South of England Genetic Epidemiology Group (SEGEG) meeting at the University of Exeter on July 1st! Registration is free and now open - forms.office.com/e/tengc4eKLk

So excited that our paper “De novo variants in the RNU4-2 snRNA cause a frequent neurodevelopmental syndrome” is out today in nature nature.com/articles/s4158… 🧵 1/16

Inarguably the most important human genetics paper of the year, and a landmark moment in the history of neurodevelopmental disorder (NDD) genetics. Mutations in RNU4-2, encoding a small nuclear RNA (snRNA) are among the most frequent genetic causes of NDD, explaining up to 0.4%

The Improving Black Health Outcomes BioResource is a new collaborative research programme. Our mission is to put a spotlight on Black health by investigating the health experiences and outcomes of Black people living in the UK. Find out more bit.ly/IBHO1

"Never be afraid to suggest something novel." —@Lotte_Bjerre, 2024 #LaskerAward winner, has a message for young scientists. She is recognized her for her work on GLP-1-based treatments for #obesity. #Lasker2024 #LaskerLaureate Novo Nordisk

🌟Reminder 🌟open postdoctoral role in my team, in statistical genetics. Working with our fantastic team on polygenic scores, UK Biobank, mental health disorders. Closing date: 8th October kcl.ac.uk/jobs/095205-po…

Come join us at rm 104 at 12 noon tomorrow (Friday) to enjoy the finest sandwiches that Colorado Convention Center has to offer, AND to hear about the world's largest cohort for genomics research - Our Future Health - and how it can enable your research #ASHG2024 Our Future Health

Interested in hearing about the role of #multiomics in early drug discovery? @JoannaHowson (Vice President Genetics in Drug Discovery, @NovoNordisk) will be addressing this topic at #FOG2025! Register now: hubs.la/Q02WkN510 #FOG2025

Excited to see my project at University of Oxford finally published at Nature Genetics ! Huge thanks to my co-authors Simon Myers Daniel Lawson Jonathan Marchini Garrett Hellenthal Lino Ferreira Sinan Shi , and the reviewers/editors. Read the publication here: nature.com/articles/s4158… 🚀🎉

I wrote about how population stratification in genetic analyses led to a decade of false findings and almost certainly continues to bias emerging results. But we are starting to have statistical tools to sniff it out. A 🧵: